Tariff wars and macro woes have impacted investor sentiment, weighing on stocks across various sectors. However, healthcare ...

In a head-to-head study, three continuous glucose monitoring systems show different measurements in the same person, which may affect therapeutic decision-making.

SAN DIEGO – Dexcom is bringing back Dexcom U, a name, image and license program for college athletes with diabetes.

Why it matters: Dexcom U is a one-of-a-kind name, image and likeness program designed to give college athletes with diabetes ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its ...

Simulations using mathematical models further supported why AC_Var — a CGM-derived index — could detect declines in glycemic ...

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

Singer-actor Nick Jonas recently took to social media to talk about his battle with diabetes. He revealed how being diagnosed with it at the age of 13 changed his life. Wife Priyanka Chopra took to ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Nick Jonas has given a surprising update on his diabetes journey.The Jonas Brothers member was diagnosed with type 1 diabetes ...

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...